The cash injection will also allow Corxel to start phase 2 testing in type 2 diabetes and help to fund a phase 3 programme in ...

Teva has penned a second pact with Royalty Pharma, this time securing up to $500 million to support the clinical development of a drug for vitiligo. The deal centers around TEV-‘408, an anti-IL-15 ...

In 2023, Teva made a pledge to bolster its innovative medicines portfolio without leaving behind its century-long legacy as a leading generics drugmaker. Now with its innovative drug franchise ...

Judge rejects Teva's request to pause trial for appeal 3,800 lawsuits claim Paragard IUD can break during removal First bellwether trial begins January 20 Jan 12 (Reuters) - Teva Pharmaceuticals can’t ...

Donegal Dr: Kma Westside Development Inc to Fischer Single Family Homes Iv LLC; $150,000 2558 Apple Ridge Ln: Thomas Kathy ...

Aytu BioPharma Inc (AYTU) reports a mixed quarter with decreased revenues but a promising start for its novel depression treatment, EXXUA.

Aytu BioPharma, Inc. ( AYTU) Q2 2026 Earnings Call February 3, 2026 4:30 PM EST Good day, everyone, and welcome to the Aytu ...

Add Yahoo as a preferred source to see more of our stories on Google. SEVENTEEN’s Joshua just graced the Golden Globes red carpet, and we are extremely fortunate to witness it in action. Dressed in an ...

Just a few weeks after winning the first state football championship in school history, Hough High School just improved its chances for a repeat. Catawba Ridge’s Joshua Dobson, the nation’s No. 12 ...

Teva Pharmaceutical Industries stock rose by 3% on Monday after the drugmaker issued upbeat guidance and targets for the years ahead. The company said its full-year earnings per share will be at the ...

Joshua Bay is the Student Success Reporter for Inside Higher Ed and Host of the Voices of Student Success podcast series. His writing has also appeared in The 74, The Boston Globe, The Atlanta Journal ...